MFS
ANIP icon

MSI Financial Services’s ANI Pharmaceuticals ANIP Stock Holding History

MSI Financial Services’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$8K Sell
138
-122
-47% -$7.46K ﹤0.01% 2897
2016
Q3 		$17K Buy
260
+192
+282% +$12K ﹤0.01% 2469
2016
Q2 		$4K Buy
68
+54
+386% +$2.63K ﹤0.01% 3219
2016
Q1 		$0 Hold
14
– – ﹤0.01% 3945
2015
Q4 		$1K Buy
+14
New +$603 ﹤0.01% 3577

Other funds holding ANIP

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

MSI Financial Services's ANIP Position: Q4 2016 in Review

MSI Financial Services reduced its ANI Pharmaceuticals (ANIP) stake by 47% in Q4 2016, selling an estimated $7.46K and leaving 138 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

MSI Financial Services first reported a position in ANIP in Q4 2015 and has held it in 5 quarters since. The position peaked at $17K in Q3 2016. 157 funds tracked by Wall St. Rank hold ANIP as of Q4 2016.

  • MSI Financial Services held 138 shares of ANI Pharmaceuticals worth $8K as of Q4 2016.
  • MSI Financial Services sold 122 ANI Pharmaceuticals shares in Q4 2016, an estimated $7.46K.
  • ANI Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #2897 holding.
  • MSI Financial Services first reported a position in ANI Pharmaceuticals in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's ANI Pharmaceuticals position peaked at $17K in Q3 2016.
  • 157 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.